AdmiralTweezers,,2019-05-28 14:25:00,14.773,NTLA this is so obviously under accumulation its a joke Low and slow under the radaronce it starts movingmark my words
AdmiralTweezers,,2019-05-28 14:23:00,14.752,NTLA part 4 Mr or Mrs Retail dont take my word for it Look at this funds allocation to NTLA relative to other CRISPR plays I would say they agree with metheres something there arkfundscomwpcontentfu
AdmiralTweezers,True,2019-05-28 14:16:00,14.81,NTLA part 3 only Chardan Capital appears to have a handle on whats what rocklandregistercom20190 This is a 45 stock period Prediction Before August we hit 45 The analysts need time to catch up on their overdo homework
AdmiralTweezers,,2019-05-28 14:12:00,14.78,NTLA part 2 apnewscomGlobe20Newswire Having the opportunity to join the Intellia team when the company is on the cusp of entering clinical trials with a CRISPRCas9 therapy is exciting said Dr SeppLorenzino The explosive growth of genome editing promises new ways to address serious and rare genetic diseases I look forward to making many contributions to the companys RD programs and complementing its talented scientists with my experience
AdmiralTweezers,True,2019-05-28 14:10:00,14.81,NTLA part 1 I guess the market doesnt understand the news yet biospacecomarticlereleas
AdmiralTweezers,,2019-05-28 11:29:00,14.919,CRSP NTLA EDIT ARKG Youre welcome forthgronassisindexphp
AnalystRatingsNetwork,,2019-05-28 10:14:00,14.795,Intellia Therapeuticss buy rating reiterated at Chardan Capital 5750 PT marketbeatcomstocksNASDA NTLA
aratings,,2019-05-28 09:45:00,15.014,Intellia Therapeutics NTLA Gets a Buy Rating from Chardan Capital NTLA analystratingscomarticles
